维普中文期刊产品整合服务
39篇 您的检索式:作者名="Passam F"
    题名 作者 年代 出处 被引量
1How we diagnose the antiphospholipid syndrome 显示文摘Giannakopoulos B Passam F Ioannou Y 2009Blood2009,113,5:1
2Current concepts on the pathogenesis of the antiphospholipid syndrome 显示文摘Giannakopoulos B Passam F Rahgozar S 2007Blood2007,109,42:1
3Cur rent concepts on the pathogenesis of the antiphospho- lipid syndrome显示文摘Giannakopoulos B Passam F Rahgozar S 2007Blood2007,109,42:1
4Redox control ofβ2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1显示文摘PASSAM F H RAHGOZAR S QI M 2010J Thromb Haemost2010,8,:1
5Evaluation of bone disease in multiple myeloma: acorrelation between biochem ical markers of bone metabolism and other clinical pa- rameters in untreated multiple myeloma patients显示文摘Alexandrakis M G Passam F H Marliarak I N 2002Clin Chim Acta2002,325,12:1
6Evaluation of bone disease in multiple myeloma:a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients显示文摘Alexandrakis M G Passam F H Malliaraki N 2002Clinical Chimica Acta2002,325,12:1
7Microsatelllte DNA instability and loss of heterozygosity in bronchial asthma显示文摘Paraskakis E Sourvinos G Passam F 2003Eur Respir J2003,22,6:1
8Elevated serum concentration of hepatocyte growth factor in patients, with multiple myeloma: correlation with markers of disease acticvity 显示文摘Alexandrakis M G Passam F H Sfiridaki A 2003Am J Hematol2003,72,4:1
9Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis 显示文摘Alexandrakis M G Passam F H Moschandrea I A et al 2003Am J ClinOneol2003,26,2:1
10The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 and acute phase protein levels in multiple myeloma 显示文摘Alesandrakys M G Passam F H Ganotakis E S 2003Clinlab Haematol2003,25,1:1
11Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma显示文摘Alexandrakis M G Passam F H Boula A 2003Ann Hematol2003,82,:1
12Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity显示文摘Alexandrakis M G Passam F H Sfiridaki A 2003Am J Hematol2003,72,4:1
13The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin - 6 (IL - 6) and acute phase protein levels in multiple myeloma显示文摘Alexandrakis M G Passam F H Ganotakls E S 2003Clin Lab Haem2003,25,:1
14Current con- cepts on the pathogenesis of the antiphospholipid syndrome 显示文摘Giannakopoules B Passam F Rahgozar S 2007Blood2007,109,2:1
15The clinicaland prognostic significance of erythrocyte sedimentation rate(ESR), serum interleukin-6 (IL-6) and acute phase protein levelsin multiple myeloma显示文摘Alexandrakis M G Passam F H Ganotakis E S 2003Clin Lab Haematol2003,25,1:1
16Current concepts on the pathogenesis of the antiphospholipid syndrome 显示文摘Giannakopoulos B Passam F Rahgozar S 2007Blood2007,109,2:1
17Current concepts on the pathogenesis of the antiphospholipid syndrome 显示文摘Giannakopoulos B Passam F Rahgozar S Blood0,109,2:1
18Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain 显示文摘Yu P Passam F H Yu D M 2008J Thromb Haemost2008,6,7:1
19Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain 显示文摘Yu P Passam F H Yu D M 2008J Thromb Haemost2008,6,7:1
20Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity显示文摘ALEXANDRAKIS M G PASSAM F H SFIRIDAKI A 2003Am J Hematology2003,72,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费